
CARL
Healthcare · Health Information Services · $469.2M market cap
$17.12-0.18 (-1.0%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -20.6% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | After the close | -0.42 | -0.34 | +19.0% |
| Aug 5, 2026 | After the close | -0.40 | -0.39 | +2.5% |
| May 5, 2026 | After the close | -0.39 | -0.26 | +33.3% |
| Feb 19, 2026 | Time not confirmed | -0.35 | -0.32 | +7.5% |
| Nov 6, 2025 | After the close | -0.49 | -0.37 | +24.5% |
| Aug 28, 2025 | After the close | -0.91 | -1.37 | -50.5% |
| Jun 26, 2025 | Time not confirmed | -0.25 | -0.26 | -4.0% |
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting…